Neuropeptides and nociception: recent advances and therapeutic implications.
Dickinson
T
T
Department of Preclinical Veterinary Sciences, Royal (Dick) School of Veterinary Studies, University of Edinburgh, UK.
Fleetwood-Walker
S M
SM
D000698:Analgesia; D000818:Animals; D030801:Animals, Genetically Modified; D006801:Humans; D019636:Neurodegenerative Diseases / Q000188:drug therapy; D009479:Neuropeptides / Q000494:pharmacology / Q000502:physiology*; D018013:Receptors, Neuropeptide / Q000819:agonists* / Q000037:antagonists & inhibitors*; D051236:Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide; D011979:Receptors, Pituitary Hormone / Q000187:drug effects; D018005:Receptors, Vasoactive Intestinal Peptide / Q000187:drug effects; D013373:Substance P / Q000037:antagonists & inhibitors; D009435:Synaptic Transmission / Q000187:drug effects
D009479:Neuropeptides; D018013:Receptors, Neuropeptide; D051236:Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide; D011979:Receptors, Pituitary Hormone; D018005:Receptors, Vasoactive Intestinal Peptide; D013373:Substance P